Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma | 8 | 2015 | 16 | 2.700 |
Why?
|
| Retinal Neoplasms | 5 | 2015 | 11 | 1.880 |
Why?
|
| MicroRNAs | 3 | 2015 | 426 | 0.960 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2007 | 239 | 0.520 |
Why?
|
| Nuclear Proteins | 2 | 2007 | 307 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2015 | 807 | 0.440 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 26 | 0.430 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1198 | 0.400 |
Why?
|
| Optic Nerve | 1 | 2009 | 28 | 0.350 |
Why?
|
| Cell Line, Tumor | 6 | 2015 | 2231 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2007 | 213 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 40 | 0.300 |
Why?
|
| Topotecan | 1 | 2005 | 4 | 0.270 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 23 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 75 | 0.260 |
Why?
|
| Antigens, CD | 1 | 2005 | 121 | 0.260 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1371 | 0.180 |
Why?
|
| Mice | 4 | 2012 | 5913 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 259 | 0.140 |
Why?
|
| Humans | 9 | 2024 | 37093 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 643 | 0.140 |
Why?
|
| Rats | 4 | 2009 | 3483 | 0.130 |
Why?
|
| Animals | 6 | 2012 | 15081 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 229 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 935 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 626 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2009 | 7 | 0.090 |
Why?
|
| Dependovirus | 1 | 2009 | 12 | 0.090 |
Why?
|
| Cadherins | 1 | 2009 | 90 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 47 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 158 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2009 | 212 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 251 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 502 | 0.080 |
Why?
|
| Apoptosis | 2 | 2005 | 1398 | 0.080 |
Why?
|
| Disease Progression | 1 | 2009 | 601 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 11 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2006 | 26 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 27 | 0.070 |
Why?
|
| Imidazoles | 1 | 2006 | 126 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 41 | 0.070 |
Why?
|
| Vincristine | 1 | 2005 | 14 | 0.070 |
Why?
|
| Carboplatin | 1 | 2005 | 13 | 0.070 |
Why?
|
| Piperazines | 1 | 2006 | 111 | 0.070 |
Why?
|
| G1 Phase | 1 | 2005 | 33 | 0.070 |
Why?
|
| Cell Division | 1 | 2006 | 307 | 0.070 |
Why?
|
| Etoposide | 1 | 2005 | 22 | 0.070 |
Why?
|
| Cell Line | 1 | 2009 | 1354 | 0.070 |
Why?
|
| S Phase | 1 | 2005 | 37 | 0.070 |
Why?
|
| Cell Death | 1 | 2006 | 267 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 1618 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2005 | 75 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2005 | 130 | 0.060 |
Why?
|
| Eye | 1 | 2005 | 71 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 177 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 227 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2005 | 343 | 0.060 |
Why?
|
| DNA Damage | 1 | 2006 | 352 | 0.060 |
Why?
|
| Retina | 1 | 2006 | 280 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2024 | 149 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2005 | 933 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1039 | 0.050 |
Why?
|
| Gene Expression | 1 | 2005 | 674 | 0.050 |
Why?
|
| Cell Survival | 1 | 2005 | 864 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.050 |
Why?
|
| Female | 2 | 2012 | 20969 | 0.050 |
Why?
|
| Time Factors | 1 | 2005 | 1742 | 0.050 |
Why?
|
| Male | 2 | 2024 | 20025 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 803 | 0.040 |
Why?
|
| Adult | 1 | 2012 | 11712 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 90 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 122 | 0.020 |
Why?
|
| Child | 1 | 2009 | 3131 | 0.010 |
Why?
|